Myeloperoxidase Expression in Acute Myeloid Leukemia Helps Identifying Patients to Benefit from Transplant

Purpose Despite extensive study, the use of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia (AML) vary considerably. The decision of which of these options to choose is complex and depends on both clinical and molecular variables as well as the availability and histocompatability of donor stem cells. So far there is no clear explanation on whether the expression of myeloperoxidase (MPO) relates to the prognosis of AML. Materials and Methods We retrospectively analyzed the prognostic significance of the MPO expression in the 140 patients with diagnosed AML treated at a single institution. Results In our study, MPO expression was associated with disease-free survival (DFS) and transplant was beneficial to overcome a negative prognostic effect of MPO-negative at diagnosis based upon the result that the DFS in patients received transplants are not significant between the MPO-positive group and MPO-negative group although DFS in all patients was different according to MPO expression. Conclusion MPO expression at diagnosis helps to choose therapy for each AML patient and can differentiate AML patients who need transplantation.

• Publication year

  2012

• Venue

  Yonsei medical journal

• Publication date

  2012-03-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.3349/ymj.2012.53.3.530PMID 22476996PMCID 3343448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Independent prognostic factors for AML outcome.

  2009cited by this paper
• Expression of myeloperoxidase enhances the chemosensitivity of leukemia cells through the generation of reactive oxygen species and the nitration of protein

  2008cited by this paper
• Impact of Cytogenetics on Clinical Outcome in AML

  2007influential reference
• Acute Myelogenous Leukemia

  2007cited by this paper
• EBMT activity survey 2004 and changes in disease indication over the past 15 years

  2006cited by this paper
• The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype

  2003cited by this paper
• Morphological diagnoses of the Japan Adult Leukemia Study Group acute myeloid leukemia protocols: Central review

  2001cited by this paper
• Molecular cytogenetic analysis of breast cancer cell lines

  2000cited by this paper
• The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

  1998cited by this paper
• Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

  1995cited by this paper
• Prognostic significance of cytochemical analysis of leukemic M2 blasts

  1992cited by this paper
• Prognostic significance of myeloperoxidase positivity of blast cells in acute myeloblastic leukemia without maturation (FAB: M1): an ECOG study.

  1989influential reference
• Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

  1985cited by this paper
• [Classification of acute non-lymphocytic leukemia based on the distribution picture of peroxidase activity and cell size. Correlation between the classification and therapeutic response].

  1983cited by this paper
• The role of bone marrow transplantation in the treatment of acute leukemia in remission.

  1982cited by this paper
• Bone-marrow transplantation for acute leukaemia in first remission.

  1982cited by this paper
• ROYAL COLLEGE OF PHYSICIANS. THE NEW BUILDING.

  1964cited by this paper

• A proteogenomic gene signature defines prognostic subgroups highlighting PI3K/AKT/mTOR signaling pathway as a therapeutic vulnerability in myeloid malignancies

  2025cites this paper
• Targeting Myeloperoxidase in Disease Pathogenesis: Emerging Roles of Natural Products in Therapeutic Modulation.

  2025cites this paper
• Acute promyelocytic leukemia with acute perforating appendicitis: A rare occurrence of medical and surgical emergency

  2023cites this paper
• Neuroprotective effects of methyl jasmonate in male Wistar rats exposed to delayed acetic acid-induced ulcerative colitis: involvement of antioxidant status, GFAP, and IBA-1 immunoreactivities

  2023cites this paper
• Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia

  2022cites this paper
• Isolated Myeloperoxidase Immunohistochemical Expression in Bone Marrow Biopsy Depicts Clinical Outcomes in Adults with Typical B-Acute Lymphoblastic Leukemia

  2021cites this paper
• Myeloperoxidase: Growing importance in cancer pathogenesis and potential drug target.

  2021cites this paper
• An ensemble machine learning model based on multiple filtering and supervised attribute clustering algorithm for classifying cancer samples

  2021cites this paper
• Modulatory action of Moringa oleifera Lam. on L-arginine induced acute pancreatitis

  2021cites this paper
• Importance of targeted therapies in acute myeloid leukemia

  2021cites this paper
• On the Clinical Pharmacology of Reactive Oxygen Species

  2020cites this paper
• Targeting Myeloperoxidase Disrupts Mitochondrial Redox Balance and Overcomes Cytarabine Resistance in Human Acute Myeloid Leukemia.

  2019cites this paper
• IMPROVED BIOMARKER-BASED DIAGNOSTICS OF LEUKEMIA SUBTYPES USING MACHINE LEARNING METHODS

  2019cites this paper
• ROLE OF PROGNOSTIC VARIABLES OF MEDICAL IMPORTANCE AND THEIR INTERPLAY IN LEUKEMIA: A STUDY FROM LOCAL POPULATION

  2019cites this paper
• Transition from morphologic diagnosis to immunophenotypic diagnosis of acute leukemia—experience of establishing a new flow cytometry laboratory

  2019cites this paper
• A new optimal gene selection approach for cancer classification using enhanced Jaya-based forest optimization algorithm

  2019cites this paper
• Gene expression of hENT1, dCK, CDA, dCMPD and topoisomerase IIα as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin

  2018cites this paper
• Clinical presentation of acute myeloid leukaemia - A decade-long institutional follow-up.

  2017cites this paper
• Development of a two-stage gene selection method that incorporates a novel hybrid approach using the cuckoo optimization algorithm and harmony search for cancer classification

  2017cites this paper
• Immunophenotypic Profile in Adult Patients with Acute Leukemia Association with Clinical Feature: Fluorescence Cytometry Quantitative Analysis

  2017cites this paper
• The deregulated promoter methylation of the Polo-like kinases as a potential biomarker in hematological malignancies

  2015cites this paper
• CD31陽性ミエロペルオキシダーゼ（MPO）陰性のmyeloid sarcomaの1例

  2015cites this paper
• [Expression of cMPO in 502 cases of acute myeloid leukemia (AML) and its diagnosis significance in AML subtypes].

  2015cites this paper
• 502例急性髓系白血病患者髓过氧化物酶的表达及其在分型诊断中的意义

  2015cites this paper